This week, once again, companies across the biotech sector continued to re-evaluate their pipelines and trim their workforces in a bid to conserve cash and extend their financial runway. Meanwhile, the regulatory landscape saw positive momentum with both new drug approvals and expanded indications. Against a backdrop of growing attention on monkeypox, Siga Technologies' Mpox vaccine candidate failed to impress in a clinical trial. Nevertheless, the company maintains a positive outlook regarding the treatment's future potential.
Let's dive into the details.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.